Spravato Feature + Unbranded Banner in “MPR First Look” Email Newsletter
![](https://oncedailypharma.com/wp-content/uploads/2019/04/spravato-mpr.jpg)
Brand: Spravato (esketamine), Nasal Spray
Parent Company: Janssen
Drug Type: Boxed Warning
Drug Category: Central Nervous System
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.spravato.com/
HCP Website: https://www.spravatohcp.com/